Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Arrow, Bidstack, Clean,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Arrow, Bidstack, Clean,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, African Pioneer, Bango,
Love Hemp (LIFE), the brand-led consumer goods company, announced that TESCO PLC, is now stocking Love Hemp CBD products. Tesco will initially stock a range of six Love Hemp products
i3 Energy (I3E), an independent oil and gas company, announced its Q2 2022 operational and financial update, in advance of its half year results which will be released in September
Bens Creek Group (BEN), the owner of a metallurgical coal mine in North America, announced that it has raised £6.0 million, perhaps something of a bolt from the blue.
Jubilee Metals (JLP), a diversified leader in metals processing, announced the performance of its operations and progress on growth projects for the six-month period to 30 June 2022.
Powerhouse Energy Group (PHE), the UK technology company commercialising hydrogen production from plastic, provided an operational update.
Lift Global Ventures (LFT), an enterprise company formed to identify investment and acquisition opportunities within the financial media and related technology industries, said that trading in its ordinary shares will
It’s been a tough week amid the ongoing political turmoil at Westminster: the Tories are in trouble again and our government appears to be quickly deteriorating following a wave of
Shell pulled out of a major North Sea oil project that was supposed to help secure UK energy supplies. This was in addition to lacklustre political support from Westminster and
Shareholders of Open Orphan (ORPH) have something to look for as it said that data from the first-in-human Phase I clinical study evaluating the safety, immunogenicity, and in vitro efficacy